(Q38464310)

3 September 2017

title

Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma (English)

1 reference

3 September 2017

1 reference

A Bánkfalvi

1

1 reference

3 September 2017

K Tory

2

1 reference

3 September 2017

M Kemper

3

1 reference

3 September 2017

D Breukelmann

4

1 reference

3 September 2017

C Cubick

5

1 reference

3 September 2017

C Poremba

6

1 reference

3 September 2017

L Füzesi

7

1 reference

3 September 2017

R J Lellè

8

1 reference

3 September 2017

W Böcker

9

1 reference

3 September 2017

publication date

1 January 2000

1 reference

Pathology, Research and Practice

3 September 2017

published in

1 reference

3 September 2017

volume

196

1 reference

3 September 2017

issue

7

1 reference

3 September 2017

page(s)

489-501

1 reference

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Prognostic significance of TP53 alterations in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Wet autoclave pretreatment for immunohistochemical demonstration of oestrogen receptors in routinely processed breast carcinoma tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

The clinical significance of p53 aberrations in human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

P53 expression in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

A new germline TP53 gene mutation in a family with Li-Fraumeni syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

p21/WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

William L. McGuire Memorial Symposium. The role and prognostic significance of p53 gene alterations in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

p53 in tumour pathology: can we trust immunohistochemistry?--Revisited!

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Mdm2 promotes the rapid degradation of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Prognostic value of bcl-2 expression in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

p53 protein as a prognostic indicator in breast carcinoma: a comparison of four antibodies for immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Regulation of p53 stability by Mdm2

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Biological indices in the assessment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

p53 protein expression in breast cancer as related to histopathological characteristics and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

bcl-2: role in epithelial differentiation and oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Immunohistochemically detectable p53 and mdm-2 oncoprotein expression in colorectal carcinoma: prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Immunophenotypic analysis of normal mucosa and squamous cell carcinoma of the oral cavity

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Immunohistochemical detection of p53 protein in archival tissues from squamous cell carcinomas of the oral cavity using wet autoclave antigen retrieval

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Frequency and spectrum of p53 mutations in gastric cancer--a molecular genetic and immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

MDM2 gene amplification in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

p53 function and dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

p21(Waf1/Cip1) and p53 protein expression in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

The p53-mdm-2 autoregulatory feedback loop

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

p21 is a universal inhibitor of cyclin kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980051-5

7 January 2021

10.1016/S0344-0338(00)80051-5

Identifiers

DOI

0 references

1 reference